SAT-156 RENAL, CARDIOVASCULAR, AND SAFETY OUTCOMES OF CANAGLIFLOZIN ACCORDING TO BASELINE ALBUMINURIA: A CREDENCE SECONDARY ANALYSIS
Jardine, M., Zhou, Z., Heerspink, H.J.L., Li, Q., Agarwal, R., Bakris, G., Charytan, D.M., Oh, R., Pollock, C., Wheeler, D.C., Zeeuw, D.D., Zhang, H., Zinman, B., Mahaffey, K.W., Perkovic, V.Volume:
5
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2020.02.166
Date:
March, 2020
File:
PDF, 220 KB
2020